Interestingly, upon MAT2A inhibition, we detected the cholesterol efflux transporters ABCG1 and ABCA1 of the cholesterol metabolism to be significantly upregulated, resulting in known anti-proliferative and apoptotic effects in hematological diseases [33,34]. This evidence concerns the gene MAT2A and hematologic disorder.